[HTML][HTML] Urticaria: collegium internationale allergologicum (CIA) update 2020
This update on chronic urticaria (CU) focuses on the prevalence and pathogenesis of
chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome …
chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome …
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Mast cells are (in) famous for their role in allergic diseases, but the physiological and
pathophysiological roles of this ingenious cell are still not fully understood. Mast cells are …
pathophysiological roles of this ingenious cell are still not fully understood. Mast cells are …
Pruritus as a distinctive feature of type 2 inflammation
S Garcovich, M Maurelli, P Gisondi, K Peris… - Vaccines, 2021 - mdpi.com
Pruritus is a common symptom of several skin diseases, both inflammatory and neoplastic.
Pruritus might have a tremendous impact on patients' quality of life and strongly interfere …
Pruritus might have a tremendous impact on patients' quality of life and strongly interfere …
[HTML][HTML] The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
M Sánchez-Borges, IJ Ansotegui, I Baiardini… - World Allergy …, 2021 - Elsevier
This is Part 1 of an updated follow-up review of a World Allergy Organization (WAO) position
paper published in 2012 on the diagnosis and treatment of urticaria and angioedema. Since …
paper published in 2012 on the diagnosis and treatment of urticaria and angioedema. Since …
Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases
Chronic urticaria (CU) is a mast cell (MC)‐dependent disease with limited therapeutic
options. Current management strategies are directed at inhibiting IgE‐mediated activation of …
options. Current management strategies are directed at inhibiting IgE‐mediated activation of …
[HTML][HTML] Targeting downstream type 2 cytokines or upstream epithelial alarmins for severe asthma
Biologics, including omalizumab, mepolizumab, benralizumab, and dupilumab, targeting
downstream IgE, cytokines IL-5, and IL-4/13, respectively, have shown promising effects in …
downstream IgE, cytokines IL-5, and IL-4/13, respectively, have shown promising effects in …
The role of coagulation and complement factors for mast cell activation in the pathogenesis of chronic spontaneous urticaria
Y Yanase, S Takahagi, K Ozawa, M Hide - Cells, 2021 - mdpi.com
Chronic spontaneous urticaria (CSU) is a common skin disorder characterized by an almost
daily recurrence of wheal and flare with itch for more than 6 weeks, in association with the …
daily recurrence of wheal and flare with itch for more than 6 weeks, in association with the …
British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021
RA Sabroe, F Lawlor, CEH Grattan… - British Journal of …, 2022 - academic.oup.com
British Association of Dermatologists guidelines for the management of people with chronic
urticaria 2021* | British Journal of Dermatology | Oxford Academic Skip to Main Content …
urticaria 2021* | British Journal of Dermatology | Oxford Academic Skip to Main Content …
Validation of the Angioedema Control Test (AECT)—a patient-reported outcome instrument for assessing angioedema control
K Weller, T Donoso, M Magerl… - The Journal of Allergy …, 2020 - Elsevier
Background Recurrent angioedema (RA) is an important clinical problem in routine care and
emergency medicine. As of recently, the only validated tools to specifically assess disease …
emergency medicine. As of recently, the only validated tools to specifically assess disease …